Stay informed on coronavirus (COVID-19).    Read More

Contact Us

In the News


Stay informed on coronavirus (COVID-19)

MinibarRx® RightNow Inventory™ Technology Eases Clinicians' Burden of Managing Complex COVID-19 Vaccines

MinibarRx®, a subsidiary of FFF Enterprises, Inc., added features to its proven technology solutions to help clinicians monitor and track COVID-19 vaccines using their proprietary RightNow Inventory™ management technology. MinibarRx offers a robust solution to streamline and manage the entire COVID-19 vaccine supply chain, from distribution to on-site patient administration, by connecting tens of thousands of micro-distribution centers nationwide.
March 2020.

Rest assured MinibarRx is available for you

As a culture of caring, we at MinibarRx take the health and well-being of our team members, customers and the patients you serve very seriously. Each of us plays a vital role in preventing the spread of coronavirus disease 2019 (COVID-19).
March 2020.

Preparing Your Patients for Coronavirus

With the growing prevalence of coronavirus disease 2019 (COVID-19) in the U.S., it is important for healthcare providers to be aware of who is most at risk for contracting the disease and developing severe or life-threatening illness, and to provide their patients with the information they need to protect themselves.
March 2020.


FFF Enterprises and its subsidiaries, Nufactor, MinibarRx and InCircle achieve HITRUST CSF® Certification to Manage Risk, Improve Security Posture, and Meet Compliance Requirements

Heralded as the nation's leading supplier of critical-care biopharmaceuticals, plasma products and vaccines, FFF Enterprises, Inc., is proud to announce it has earned Certified status for information security by HITRUST.
January 2020

New Vaccines to Protect Infants Against Infections

Vaccinations are currently unavailable to infants until 6 months of age since a newborn carries their mother's antibodies – causing the body to shut down immune defenses when initiated by conventional vaccines. According to a preclinical study in Science Translational Medicine, a specialized modified-RNA (Mrna) influenza vaccine could potentially overcome a mother's antibodies and protect infants against infections.
January 2020 Source: Science Daily / University of Pennsylvania School of Medicine.

Why the Pharma Industry Depends on In-Stock and Cold-Chain Compliant Biopharma Products

The pharma industry has long been tasked with the arduous and expensive task of biopharma product storage and inventory.
September 2019

Summer Travel Alerts Updated

CDC Travel Alerts inform international travelers about the importance of travel vaccines and when and how to get vaccinated.
August 11, 2019

American College of Physicians reminds adults: Vaccines are not just for children

The American College of Physicians (ACP) reminds adults about the importance of vaccinations for protection against many common and serious diseases.
July 30, 2019

Following the Disease: Trends and Outbreaks Drive Subtle Changes to Vaccine Recommendations for Adolescents and Young Adults

Recent outbreaks and immunization success stories are driving vaccine recommendation changes at the national level, leading to small but mighty steps in the continuing fight against vaccine-preventable diseases.
June, 2019

Vaccines for Seniors: Addressing Compliance

Several challenges promote a disconnect between preventative vaccines and compliance in older adults.
June, 2019

Update on Conventional vs. DNA Vaccines

New vaccine technology may one day help to prevent diseases, as well as treat cancer, once challenges are overcome.
June, 2019